117 related articles for article (PubMed ID: 3298077)
21. Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas.
Zijlstra M; Vasmel WL; Voormanns M; de Goede RE; Schoenmakers HJ; Nieland J; Slater RM; Melief CJ
J Exp Med; 1986 May; 163(5):1213-26. PubMed ID: 3486245
[TBL] [Abstract][Full Text] [Related]
22. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
23. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
24. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
Harris NL; Bhan AK
Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
[TBL] [Abstract][Full Text] [Related]
25. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
[TBL] [Abstract][Full Text] [Related]
26. Histomorphologic and immunophenotypic spectrum of primary gastro-intestinal B-cell lymphomas.
Mielke B; Möller P
Int J Cancer; 1991 Feb; 47(3):334-43. PubMed ID: 1704353
[TBL] [Abstract][Full Text] [Related]
27. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
29. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features.
Li G; Hansmann ML; Zwingers T; Lennert K
Histopathology; 1990 Jun; 16(6):519-31. PubMed ID: 2198222
[TBL] [Abstract][Full Text] [Related]
30. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas.
Williamson JM; Grigor I; Smith ME; Holgate CS; Quirke P; Bird CC; Alison DL; Child JA
J Pathol; 1986 Sep; 150(1):51-9. PubMed ID: 3491205
[TBL] [Abstract][Full Text] [Related]
31. MHC class I and class I-like gene product expression by malignant T cells: relationships between CD1a, HLA-ABC and beta 2-microglobulin.
Jones RA; Scott CS; Katz FE; Child JA
Clin Exp Immunol; 1988 Dec; 74(3):454-8. PubMed ID: 2466592
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
33. Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.
Hauschild A; Sterry W
Am J Pathol; 1989 Jul; 135(1):177-84. PubMed ID: 2774058
[TBL] [Abstract][Full Text] [Related]
34. [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas].
Smolle J; Kaudewitz P; Aberer E; Torne R; Burg G; Kerl H
Hautarzt; 1987 Aug; 38(8):461-6. PubMed ID: 3308776
[TBL] [Abstract][Full Text] [Related]
35. Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course.
Amiot L; Onno M; Lamy T; Dauriac C; Le Prise PY; Fauchet R; Drenou B
Br J Haematol; 1998 Mar; 100(4):655-63. PubMed ID: 9531330
[TBL] [Abstract][Full Text] [Related]
36. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
37. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
[TBL] [Abstract][Full Text] [Related]
38. Malignant non-Hodgkin lymphomas of the epipharynx and the mesopharynx including tonsils, paranasal sinuses and neck. Histological reclassification using the "Kiel-classification".
Katenkamp D; Löbe LP; Stiller D
Arch Geschwulstforsch; 1979; 49(5):448-55. PubMed ID: 518255
[TBL] [Abstract][Full Text] [Related]
39. Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma.
Tomita Y; Matsumoto Y; Nishiyama T; Fujiwara M
J Pathol; 1990 Oct; 162(2):157-64. PubMed ID: 2250194
[TBL] [Abstract][Full Text] [Related]
40. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN
Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
